Latest filing published 26 Nov 2019 for Matinas BioPharma Holdings, Inc., €40k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -11.0%Entry US$59.00 · Close at T+365 US$52.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Keith A. Kucinski: trading record in brief
Keith A. Kucinski appears in our data through filings on Matinas BioPharma Holdings, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 22 November 2019 to 25 November 2019.
On the market, this insider has only ever bought: 2 purchases, €104k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 26 November 2019: an open-market purchase of €40k, in Matinas BioPharma Holdings, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Keith A. Kucinski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 36,500 shares@ US$1.2037.9% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-19-018412:0Canonical exit: 20 Feb 2020 (T+90)
- 58,000 shares@ US$1.2362.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-19-018412:1Canonical exit: 23 Feb 2020 (T+90)
2 of 2 declarations